October 1, 2018 — Socium Therapeutics has been selected to present at the BIO Investor Forum in San Francisco on October 18, 2018. Tim Salmon, CEO of Socium, commented, “I’m really excited to present in San Francisco. We have been meeting with many venture funds and potential strategic partners over the past month, but I have not had an opportunity to go out to California. The opportunity to present will give us the platform to inform a different group of investors and potential partners about our progress at Socium, developing our orally-administered, therapeutic cancer vaccine platform.”